documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
19 rows where agency_id = "DEA", document_type = "Rule" and posted_year = 2025 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: docket_id, title, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEA-2023-0029-41937 | DEA | Telemedicine Prescribing of Controlled Substances (DEA407) DEA-2023-0029 | Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications | Rule | 2025-12-31T05:00:00Z | 2025 | 12 | 2025-12-31T05:00:00Z | 2026-01-13T03:01:01Z | 2025-24123 | 0 | 0 | 09000064b9113f32 | ||
| DEA-2023-0147-0004 | DEA | Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I (DEA1143) DEA-2023-0147 | Schedules of Controlled Substances: Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I | Rule | 2025-12-23T05:00:00Z | 2025 | 12 | 2025-12-23T05:00:00Z | 2026-01-06T01:10:17Z | 2025-23717 | 0 | 0 | 09000064b91067de | ||
| DEA-2025-0918-0001 | DEA | Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act (DEA1604) DEA-2025-0918 | Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act | Rule | 2025-12-16T05:00:00Z | 2025 | 12 | 2025-12-16T05:00:00Z | 2025-12-16T21:28:16Z | 2025-22960 | 0 | 0 | 09000064b90da7df | ||
| DEA-2025-0555-0055 | DEA | Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I (DEA1356) DEA-2025-0555 | Schedules of Controlled Substances: Extension of Temporary Placement of MDMB-4en-PINACA in Schedule I | Rule | 2025-12-11T05:00:00Z | 2025 | 12 | 2025-12-11T05:00:00Z | 2025-12-11T19:41:46Z | 2025-22540 | 0 | 0 | 09000064b90c55b5 | ||
| DEA-2025-0852-0002 | DEA | Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511) DEA-2025-0852 | Schedules of Controlled Substances: Extension of Temporary Placement of CUMYL-PEGACLONE in Schedule I | Rule | 2025-12-11T05:00:00Z | 2025 | 12 | 2025-12-11T05:00:00Z | 2025-12-11T19:46:09Z | 2025-22496 | 0 | 0 | 09000064b90c55b7 | ||
| DEA-2024-0144-0006 | DEA | Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I (DEA1246) DEA-2024-0144 | Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I | Rule | 2025-11-17T05:00:00Z | 2025 | 11 | 2025-11-17T05:00:00Z | 2025-11-20T02:13:12Z | 2025-20004 | 0 | 0 | 09000064b9085a3d | ||
| DEA-2025-0588-0001 | DEA | Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I (DEA1494) DEA-2025-0588 | Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I | Rule | 2025-10-15T04:00:00Z | 2025 | 10 | 2025-10-15T04:00:00Z | 2025-10-17T03:23:35Z | 2025-19542 | 0 | 0 | 09000064b901aa49 | ||
| DEA-2025-0558-0001 | DEA | Requiring Online Submission of Applications for and Renewals of DEA Registration; Correction (DEA1111) DEA-2025-0558 | Requiring Online Submission of Applications for and Renewals of DEA Registration; Correction | Rule | 2025-10-02T04:00:00Z | 2025 | 10 | 2025-10-02T04:00:00Z | 2025-10-03T01:30:04Z | 2025-19292 | 0 | 0 | 09000064b8ff064c | ||
| DEA-2023-0016-0010 | DEA | Controlled Substances Ordering System Modernization (DEA732) DEA-2023-0016 | Controlled Substances Ordering System Modernization | Rule | 2025-10-02T04:00:00Z | 2025 | 10 | 2025-10-02T04:00:00Z | 2025-10-03T01:31:47Z | 2025-19325 | 0 | 0 | 09000064b8ff074c | ||
| DEA-2025-0556-0001 | DEA | Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical DEA-2025-0556 | Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical | Rule | 2025-10-02T04:00:00Z | 2025 | 10 | 2025-10-02T04:00:00Z | 2025-10-03T01:20:48Z | 2025-19349 | 0 | 0 | 09000064b8ff07c5 | ||
| DEA-2024-0148-0006 | DEA | Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act (DEA1457) DEA-2024-0148 | Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I | Rule | 2025-09-18T04:00:00Z | 2025 | 9 | 2025-09-18T04:00:00Z | 2025-10-03T01:28:48Z | 2025-18103 | 0 | 0 | 09000064b8fb0ed1 | ||
| DEA-2024-0118-0003 | DEA | Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I (DEA1337) DEA-2024-0118 | Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I | Rule | 2025-08-15T04:00:00Z | 2025 | 8 | 2025-08-15T04:00:00Z | 2025-08-15T17:55:48Z | 2025-15566 | 0 | 0 | 09000064b8f008ec | ||
| DEA-2025-0192-0003 | DEA | Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance (DEA1390) DEA-2025-0192 | Specific Listing for Dipentylone, A Currently Controlled Schedule I Substance | Rule | 2025-08-08T04:00:00Z | 2025 | 8 | 2025-08-08T04:00:00Z | 2025-09-10T04:16:28Z | 2025-15177 | 0 | 0 | 09000064b8ef0c9b | ||
| DEA-2022-0145-0005 | DEA | Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989) DEA-2022-0145 | Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I | Rule | 2025-07-25T04:00:00Z | 2025 | 7 | 2025-07-25T04:00:00Z | 2025-07-25T16:18:35Z | 2025-14037 | 0 | 0 | 09000064b8e9cab5 | ||
| DEA-2024-0026-0002 | DEA | Placement of 2-Methyl AP-237 in Schedule I (DEA1245) DEA-2024-0026 | Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I; Correction | Rule | 2025-06-03T00:00:00Z | 2025 | 6 | 2025-06-03T00:00:00Z | 2025-06-03T21:07:54Z | 2025-09989 | 0 | 0 | 09000064b8dceccb | ||
| DEA-2023-0028-2951 | DEA | Expansion of Induction of Buprenorphine via Telemedicine Encounter (DEA948) DEA-2023-0028 | Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients | Rule | 2025-03-24T04:00:00Z | 2025 | 3 | 2025-03-24T04:00:00Z | 2025-06-03T00:09:09Z | 2025-05007 | 0 | 0 | 0900006486a29032 | ||
| DEA-2023-0028-2918 | DEA | Expansion of Induction of Buprenorphine via Telemedicine Encounter (DEA948) DEA-2023-0028 | Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients | Rule | 2025-02-19T05:00:00Z | 2025 | 2 | 2025-02-19T05:00:00Z | 2025-03-01T04:59:59Z | 2025-03-01T23:55:45Z | 2025-02793 | 0 | 0 | 0900006486971375 | |
| DEA-2023-0028-2917 | DEA | Expansion of Induction of Buprenorphine via Telemedicine Encounter (DEA948) DEA-2023-0028 | Expansion of Buprenorphine Treatment via Telemedicine Encounter | Rule | 2025-01-17T05:00:00Z | 2025 | 1 | 2025-01-17T05:00:00Z | 2025-01-21T13:53:50Z | 2025-01049 | 0 | 0 | 09000064868e2eb2 | ||
| DEA-2023-0029-35464 | DEA | Telemedicine Prescribing of Controlled Substances (DEA407) DEA-2023-0029 | Continuity of Care via Telemedicine for Veterans Affairs Patients | Rule | 2025-01-17T05:00:00Z | 2025 | 1 | 2025-01-17T05:00:00Z | 2025-01-21T13:54:28Z | 2025-01044 | 0 | 0 | 09000064868e2ffd |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;